AHA Coding Clinic® for HCPCS - 2016 Quarter 4
JW modifier information update
What is the JW modifier? ...
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS guidance on the JW modifier, including a frequently asked questions update, the applicable Medicare Part B policy context, and related documentation and reporting expectations. It is relevant for billing and coding professionals who work with drug claims, Medicare compliance, and HCPCS Level II modifiers, and it references CMS policy resources and manual guidance.
Why This Topic Matters
Understanding the CMS update helps billing and coding staff recognize the reporting framework for discarded drugs and biologicals under Medicare Part B and align claim handling with current Medicare guidance.
Article Sections
-
General
Introduces the CMS FAQ context for the JW modifier and summarizes the policy topic covered by the article. It frames the discussion around Medicare Part B drug claims and discarded drug reporting.
What You Will Learn
- The CMS context for the JW modifier update
- How the article frames discarded drug reporting under Medicare Part B
- Which CMS resources and manual references are associated with the guidance
- The documentation and reporting topics addressed in the FAQs
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Revenue cycle professionals
- Healthcare providers and suppliers
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com